Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

The Consortium facilitates dialog with regulatory bodies, such as the U.S. Food and Drug Administration, in order to provide a comprehensive understanding of the regulatory climate and help develop needed standards for evaluating cancer immunotherapies.



*Immunotherapy results may vary from patient to patient.